Data Access Shouldnʼt Require a Translator In most enterprises, data access still feels like a locked room with SQL as the ...

With the official release of Microsoft's latest database offering, let's see what was improved and what still needs some work ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.

Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Every application needs authorization. It’s the backbone that decides who can access what, when, and under which conditions. But the hard part isn’t ...